Clinical Trial Update: Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial evaluating oral fish oil for parenteral nutrition-associated liver disease sponsored by Boston Children's Hospital has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parenteral Nutrition Associated Liver Disease
• Short Bowel Syndrome

Drugs mentioned

• Oral Fish Oil (omega-3 fatty acids)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Liver Disease, Short Bowel Syndrome | Phase 1, Phase 2 | Status: WITHDRAWN